SCHEMBL4830751

SCHEMBL4830751

CCN1C(=O)C(CC)(CC)c2cc3[nH]c(-c4n[nH]cc4NC(=O)C4CC4)nc3cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.43
AURKB Q96GD4 1/20 0.43
PDPK1 O15530 6/20 0.36
JAK2 O60674 2/20 0.35
TYK2 P29597 1/20 0.35
ALDH1A1 P00352 2/20 0.33
BRD4 O60885 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
OPRL1 P41146 1/20 0.32
PARP1 P09874 1/20 0.32
CLK2 P49760 1/20 0.32
CLK3 P49761 1/20 0.32
DYRK1A Q13627 1/20 0.32
KMT2A Q03164 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
FOXO1 Q12778 1/20 0.31
LMNA P02545 1/20 0.31
NR2E3 Q9Y5X4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4825532 0.94 AURKA (0.41) AURKAAURKBPDPK1JAK2TYK2
SCHEMBL4821939 0.92 AURKA (0.54) AURKAAURKBPDPK1JAK2TYK2
SCHEMBL4822663 0.90 PDPK1 (0.35) AURKAAURKBPDPK1JAK2TYK2
SCHEMBL4824803 0.88 AURKA (0.51) AURKAAURKBPDPK1JAK2TYK2
SCHEMBL4822469 0.86 AURKA (0.41) AURKAAURKBPARP1
SCHEMBL4829102 0.81 AURKA (0.57) AURKAAURKBALDH1A1KDM4ECLK2
SCHEMBL4829256 0.81 AURKA (0.38) AURKAAURKBPDPK1JAK2TYK2
SCHEMBL4827460 0.80 AURKA (0.50) AURKAAURKB
SCHEMBL4829418 0.80 AURKA (0.58) AURKAAURKBALDH1A1KDM4EHPGD
SCHEMBL4962295 0.80 AURKA (0.51) AURKAAURKBOPRL1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US claimed
US-7462639-B2 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma HOFFMANN-LA ROCHE INC. (US) 2008-12-09 US disclosed
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235065-A1 Aminopyrazole derivatives CYP3A43, CYP3A5, CYP3A4 AURKA 742/4885AURKB 1096/4885PDPK1 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.